FTSE 100 Slips as Mining and Pharma Stocks Drag Down London Market

London’s blue-chip index retreated on Monday as investors shed shares in precious metal miners and pharmaceutical heavyweight AstraZeneca. The FTSE 100 closed the session at 10,651.8 points, marking a 0.3% decline that underscored a broader wave of cautious sentiment across the city’s major trading floors.

Editorial·July 6, 2026·reads: 387

FTSE 100 Slips as Mining and Pharma Stocks Drag Down London Market

The downward pressure on the main index was mirrored in the FTSE 250, which shed 0.2% by the closing bell. Despite the prevailing gloom, the midcap sector found a rare outlier in easyJet. The airline’s stock surged to the top of its category following the company’s decision to accept a formal takeover bid, providing a sharp contrast to the losses seen elsewhere in the market.